Investors seeking a stock unrelated to artificial intelligence should take a look at Boston Scientific.
Boston Scientific Corporation continues to deliver impressive growth, driven by both organic expansion and strategic M&A, with shares reaching new highs in 2025. BSX reports nearly 20% organic sales ...
On Wednesday, Boston Scientific Corporation (NYSE:BSX) reported third-quarter 2025 revenues of $5.07 billion, beating the consensus estimate of $4.97 billion. The medical technology giant reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results